Bellevue Global Life Science Investors LLC 13D and 13G filings for Bellevue Life Sciences Acquisition Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-11 9:03 pm Unchanged |
2024-12-31 | 13G | Bellevue Life Sciences Acquisition Corp. BLAC |
Bellevue Global Life Science Investors LLC | 2,035,000 87.700% |
0 (Unchanged) |
Filing |
| 2024-08-14 08:00 am Unchanged |
2024-06-30 | 13G | Bellevue Life Sciences Acquisition Corp. BLAC |
Bellevue Global Life Science Investors LLC | 2,035,000 50.400% |
0 (Unchanged) |
Filing |
| 2024-02-08 4:20 pm Purchase |
2023-12-31 | 13G | Bellevue Life Sciences Acquisition Corp. BLAC |
Bellevue Global Life Science Investors LLC | 2,035,000 36.200% |
2,035,000 (New Position) |
Filing |